TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20871194

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 18377622

Group type: EXPERIMENTAL
Intervention: Serum enriched in marine compounds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cream formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lotion and cream formulations
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (after stopping treatment)
Number of subjects: 0
Study: 17313803

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg/d for 7 days before surgery
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combination of celecoxib 200 mg/d and octreotide 100 microg injected subcutaneously for 7 days before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no anti‐tumor medicine before GC resection)
Number of subjects: 75
Study: 12682082

Group type: EXPERIMENTAL
Intervention: Eplerenone (50 to 200 mg daily)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Amlodipine (2.5 to 10 mg daily)
Number of subjects: 269
Study: 10067694

Group type: EXPERIMENTAL
Intervention: Combined, short schedule group (Co-S) - DTaP and PRP-T vaccines reconstituted immediately prior to injection at 3, 4 and 5 months of age
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Associated, short schedule group (As-S) - DTaP + PRP-T simultaneously injected at different sites at 3, 4 and 5 months of age
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Associated, long schedule group (As-L) - DTaP + PRP-T at separate sites at 2, 4 and 6 months
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Booster vaccination with unconjugated PRP
Number of subjects: 410

Group type: COMPARATOR
Intervention: DTwP (whole-cell) vaccine
Number of subjects: 410
Study: 8537258

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ketoconazole and Itraconazole
Number of subjects: 93
Study: 2378547

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 10 mg daily
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 20 mg daily
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride 30 mg daily
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride (various doses)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride (doses over 0.3 mg/kg per day)
Number of subjects: 53
Study: 19025

Group type: EXPERIMENTAL
Intervention: Lorazepam 4 mg/70 kg i.m.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Morphine 10 mg/70 kg i.m.
Number of subjects: 20
Study: 31448111

Group type: EXPERIMENTAL
Intervention: Samata intervention (structural and norms-based intervention)
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2457

Group type: EXPERIMENTAL
Intervention: Samata intervention
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2457
Study: 27831738

Group type: EXPERIMENTAL
Intervention: TAU + WIRED (online writing intervention)
Number of subjects: 34

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 34
Study: 25308309

Group type: EXPERIMENTAL
Intervention: Left hand-movement observation task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 30
Study: 24902920

Group type: EXPERIMENTAL
Intervention: Intensive treatment targeting systolic blood pressure <120 mm Hg
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard treatment targeting systolic blood pressure <140 mm Hg
Number of subjects: 9361
Study: 23082836

Group type: EXPERIMENTAL
Intervention: HIV/AIDS and Hepatitis Health Promotion (HHP) program led by nurses
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Art Messaging (AM) program led by artists
Number of subjects: 154
Study: 19528834

Group type: EXPERIMENTAL
Intervention: Specific Resistance Training (SRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All-round Physical Exercise (APE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference Intervention (REF)
Number of subjects: 0
Study: 17288688

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 20
Study: 15354524

Group type: EXPERIMENTAL
Intervention: Alpha1‐adrenoceptor blocker (Terazosin 2 mg qn) and Levo‐ofloxacin (0.2 bid)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Levo‐ofloxacin (0.2 bid) alone
Number of subjects: 80
Study: 11571657

Group type: EXPERIMENTAL
Intervention: Venous constrictor band
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracavernous injection with prostaglandin E1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Electroejaculation (EEJ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home insemination with semen obtained by PVS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVS or EEJ combined with assisted reproduction techniques
Number of subjects: 0
Study: 9829447

Group type: EXPERIMENTAL
Intervention: Azelaic acid 20% cream and glycolic acid 15% or 20% lotion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hydroquinone 4% cream
Number of subjects: 100
Study: 8008725

Group type: EXPERIMENTAL
Intervention: dicloxacillin 500 mg 3 times a day
Number of subjects: 9

Group type: COMPARATOR
Intervention: dicloxacillin 250 mg + probenecid 250 mg 3 times a day
Number of subjects: 9
Study: 3619135

Group type: EXPERIMENTAL
Intervention: Enprofylline 2.5 mg/kg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Theophylline (standard dose)
Number of subjects: 135
Study: 31240752

Group type: EXPERIMENTAL
Intervention: Individual family intervention (n=49)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Group intervention (n=48)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 97

Group type: COMPARATOR
Intervention: Group intervention
Number of subjects: 97
Study: 29280239

Group type: EXPERIMENTAL
Intervention: www.scottga.org
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo hand-washing game
Number of subjects: 176
Study: 26867559

Group type: EXPERIMENTAL
Intervention: Structured skill training (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unstructured practice (n = 10)
Number of subjects: 20
Study: 23566045

Group type: EXPERIMENTAL
Intervention: Custom-fit mouthguards
Number of subjects: 40
Study: 22354147

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy for 13 months
Number of subjects: 103

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 103
Study: 19997019

Group type: EXPERIMENTAL
Intervention: Fat-free milk (MILK)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate (CON)
Number of subjects: 20
Study: 19005405

Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Basiliximab with MMF
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 19391530

Group type: EXPERIMENTAL
Intervention: Combined acupuncture and Chinese herb group (n=32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Simple Chinese herb group (n=31)
Number of subjects: 63
Study: 15898474

Group type: EXPERIMENTAL
Intervention: Functional Communication Training (FCT) plus punishment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Functional Communication Training (FCT)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Preference evaluation for FCT with punishment
Number of subjects: 2
Study: 11182531

Group type: EXPERIMENTAL
Intervention: Lithium treatment (acute administration for 7 days)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 11
Study: 9135307

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 4% amethocaine gel
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 7963202

Group type: EXPERIMENTAL
Intervention: Carbamazepine (modal dose 300 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 3681312

Group type: EXPERIMENTAL
Intervention: terodiline
Number of subjects: 25
Study: 30865529

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 150
Study: 29226809

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (14,000 IU weekly)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 47
Study: 26385358

Group type: EXPERIMENTAL
Intervention: Guide to Action Care Home fall prevention intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 145
Study: 24257813

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: CYP450 genotypes
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: CYP450 genotype and antidepressant serum concentration
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Differences in antidepressant serum concentrations
Number of subjects: 384
Study: 22534049

Group type: EXPERIMENTAL
Intervention: Intracoronary autologous freshly isolated bone marrow cells transplantation (BMCs‐Tx)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no cell therapy)
Number of subjects: 12
Study: 19875426

Group type: EXPERIMENTAL
Intervention: Tailored care plans for practices and patients with reviews every four months
Number of subjects: 903
Study: 17224574

Group type: EXPERIMENTAL
Intervention: Recovery from moderate disability (mRS 3) after recurrent ischemic stroke
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Recovery from severe disability (mRS 4) after recurrent ischemic stroke
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Recovery from very severe disability (mRS 5) after recurrent ischemic stroke
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Overall recovery from disability after recurrent ischemic stroke
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Time to recovery from moderate disability (mRS 3)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Time to recovery from severe disability (mRS 4)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Mortality rate among disabled patients after recurrent ischemic stroke
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Predictors of recovery from disability after recurrent ischemic stroke
Number of subjects: 345
Study: 14980334

Group type: EXPERIMENTAL
Intervention: Droperidol 2.5 mg i.v.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Prochlorperazine 10 mg i.v.
Number of subjects: 96
Study: 11207051

Group type: COMPARATOR
Intervention: Wide local excision
Number of subjects: 116

Group type: COMPARATOR
Intervention: Excision plus radiotherapy
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 116
Study: 9390984

Group type: EXPERIMENTAL
Intervention: Chronic exercise (cycling on an ergometer at 50% maximal oxygen consumption for 30 min/day, 5 days/wk, for two consecutive menstrual cycles)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chronic exercise
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acute strenuous exercise
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Deconditioning (after three menstrual cycles of no exercise)
Number of subjects: 16
Study: 8177971

Group type: EXPERIMENTAL
Intervention: Easyhaler (MDPI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional metered dose inhaler (MDI)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21
Study: 2444132

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg propofol (Disoprivan)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 1 mg/kg methohexital (Brevimytal)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 1.4 microgram fentanyl + 0.07 mg/kg droperidol (Thalamonal)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Premedication with fentanyl
Number of subjects: 82

Group type: COMPARATOR
Intervention: Comparative value from 60 examinations
Number of subjects: 82
Study: 29032402

Group type: EXPERIMENTAL
Intervention: 0.12% CHX + 0.2% NaF
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.12% CHX
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 0.2% NaF
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 27453037

Group type: EXPERIMENTAL
Intervention: 500 mL isotonic drink
Number of subjects: 4576

Group type: EXPERIMENTAL
Intervention: 500 mL water
Number of subjects: 4576

Group type: EXPERIMENTAL
Intervention: Muscle tensing exercises
Number of subjects: 4576

Group type: EXPERIMENTAL
Intervention: Isotonic drink
Number of subjects: 4576

Group type: COMPARATOR
Intervention: Advice to drink (control arm)
Number of subjects: 4576
Study: 24102515

Group type: EXPERIMENTAL
Intervention: Group psychodynamic psychotherapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Psycho-educational workshops (comparative group)
Number of subjects: 28
Study: 23678501

Group type: EXPERIMENTAL
Intervention: Implementation intentions (II) group
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Self-efficacy (SE) group
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Combination of implementation intentions and self-efficacy (II+SE) group
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group (receiving written information on nutrition)
Number of subjects: 291
Study: 20829257

Group type: EXPERIMENTAL
Intervention: Laser-assisted liposuction (Smartly MPX laser, Cynosure, Inc.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Liposuction alone
Number of subjects: 10
Study: 18721244

Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg/day
Number of subjects: 245

Group type: COMPARATOR
Intervention: Lamivudine 100 mg/day
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Entecavir 1 mg/day
Number of subjects: 245
Study: 17081466

Group type: EXPERIMENTAL
Intervention: Closed-suction drain
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 100
Study: 12131216

Group type: EXPERIMENTAL
Intervention: HIVIGLOB 50 mg/kg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HIVIGLOB 200 mg/kg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HIVIGLOB 400 mg/kg
Number of subjects: 31
Study: 10079418

Group type: EXPERIMENTAL
Intervention: Rehabilitation after myocardial infarction
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care after myocardial infarction
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Rehabilitation after identifying a recreational physical activity goal
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care after identifying a recreational physical activity goal
Number of subjects: 201
Study: 7673302

Group type: EXPERIMENTAL
Intervention: Collagenase ointment with polymyxin B sulfate/bacitracin powder
Number of subjects: 79

Group type: COMPARATOR
Intervention: Silver sulfadiazine cream (1%)
Number of subjects: 79
Study: 1981681

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg twice daily for 4 weeks, then increased to 10 mg twice daily for another 4 weeks, followed by open-label felodipine 5-15 mg twice daily for 1 year.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg once daily for 4 weeks, then increased to 50 mg once daily for another 4 weeks.
Number of subjects: 103
Study: 7376786

Group type: EXPERIMENTAL
Intervention: 5 g GABA (single dose)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 18 g GABA (daily for 4 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31779665

Group type: EXPERIMENTAL
Intervention: Subscapularis peel (SP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lesser tuberosity osteotomy (LTO)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard subscapularis tenotomy (ST)
Number of subjects: 21
Study: 28279661

Group type: EXPERIMENTAL
Intervention: Dynamic balance training (10 weeks, 4 times per week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dynamic balance training
Number of subjects: 40
Study: 25940075

Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Peak Oxygen Consumption
Number of subjects: 2152

Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Expired Volume per Unit Time/Volume of Carbon Dioxide Slope
Number of subjects: 2152

Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + 6-Minute Walk Distance (6MWD)
Number of subjects: 2152

Group type: EXPERIMENTAL
Intervention: Seattle Heart Failure Model (SHFM) + Cardiopulmonary Exercise Duration
Number of subjects: 2152

Group type: COMPARATOR
Intervention: Seattle Heart Failure Model (SHFM) alone
Number of subjects: 2152
Study: 24369771

Group type: EXPERIMENTAL
Intervention: DECISION + 2
Number of subjects: 270

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study: 21266204

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 19651504

Group type: EXPERIMENTAL
Intervention: Genuair inhaler
Number of subjects: 48

Group type: COMPARATOR
Intervention: HandiHaler A
Number of subjects: 48

Group type: COMPARATOR
Intervention: HandiHaler B
Number of subjects: 48
Study: 17000096

Group type: EXPERIMENTAL
Intervention: Bronchodilators (5 mg salbutamol plus 500 microg ipratropium bromide nebulisation)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oxygen therapy (without bronchodilators)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of oxygen and bronchodilators
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (placebo/air)
Number of subjects: 28
Study: 15087613

Group type: EXPERIMENTAL
Intervention: Alfentanil (target concentration, 80 ng/ml)
Number of subjects: 8
Study: 11414374

Group type: EXPERIMENTAL
Intervention: Critical norms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Consensus norms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group norm manipulation
Number of subjects: 0
Study: 9789907

Group type: EXPERIMENTAL
Intervention: Quetiapine fumarate treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Matched controls (n = 12)
Number of subjects: 10
Study: 7626567

Group type: EXPERIMENTAL
Intervention: NEI Scheimpflug densitometry
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: LOCS II clinical grading
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal control group (LOCS II)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 55
Study: 2924519

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Borg Scale
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both scales (VAS and Borg)
Number of subjects: 10
Study: 307810

Group type: EXPERIMENTAL
Intervention: High intensity TNS near the painful joint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low intensity TNS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNS applied at a remote site
Number of subjects: 0
Study: 30465374

Group type: EXPERIMENTAL
Intervention: Succinylcholine 1mg (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Succinylcholine (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Succinylcholine (Group C)
Number of subjects: 60
Study: 26435375

Group type: EXPERIMENTAL
Intervention: Standard therapy arm of the ACCORD trial
Number of subjects: 4685
Study: 24780946

Group type: COMPARATOR
Intervention: Hypolipidic diet (group D)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Hypolipidic diet and phyto-supplement (group E)
Number of subjects: 191
Study: 22492367

Group type: EXPERIMENTAL
Intervention: Daily consumption of hazelnuts, chocolate, and potato chips (∼1100 kJ/d) for 12 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no additional food)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: All snack food groups including control
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Baseline SSS
Number of subjects: 118
Study: 20671100

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) 3 times per week for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment (standard of care)
Number of subjects: 30
Study: 19195326

Group type: EXPERIMENTAL
Intervention: Elvitegravir/r (150/100 mg once daily) plus etravirine (200 mg twice daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Elvitegravir/r alone
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Elvitegravir/r plus etravirine
Number of subjects: 34
Study: 15741590

Group type: EXPERIMENTAL
Intervention: Brief Negotiation Interview (BNI) performed by emergency practitioners (EPs)
Number of subjects: 58
Study: 12969695

Group type: EXPERIMENTAL
Intervention: Hormone therapy (estradiol, 2 mg p.o., plus norethisterone acetate, 1 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Alendronate (10 mg)
Number of subjects: 90
Study: 10596203

Group type: EXPERIMENTAL
Intervention: Balanced anaesthetic techniques with fentanyl and halothane, isoflurane and enflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with fentanyl and midazolam
Number of subjects: 40
Study: 8540776

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham control session
Number of subjects: 10
Study: 2065688

Group type: EXPERIMENTAL
Intervention: Piroximone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitroprusside
Number of subjects: 12
Study: 6414682

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy program (specifics not provided)
Number of subjects: 142
Study: 3970673

Group type: EXPERIMENTAL
Intervention: Endarterectomized superficial femoral artery (ESFA) patch angioplasty
Number of subjects: 86

Group type: COMPARATOR
Intervention: Vein patch
Number of subjects: 86